Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Switzerland Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20041
20054
20063
20071
20082
20093
20101
20111
20131
20141
20153
20163
20192
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated6
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute8
Bayer6
Hoffmann-La Roche3
ETOP IBCSG Partners Foundation2
European Organisation for Research and Treatment of Cancer - EORTC2
Puma Biotechnology, Inc.2
Sanofi2
AstraZeneca1
Genentech, Inc.1
Jules Bordet Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms34
Neoplasms5
Neoplasm Metastasis4
Brain Neoplasms3
Burkitt Lymphoma2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2
Endometrial Neoplasms2
Esophageal Neoplasms2
Hodgkin Disease2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.